rs61752108
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The ENST00000225873.9(PEX12):βc.744_745insTβ(p.Thr249TyrfsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. S248S) has been classified as Likely benign.
Frequency
Consequence
ENST00000225873.9 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX12 | NM_000286.3 | c.744_745insT | p.Thr249TyrfsTer14 | frameshift_variant | 3/3 | ENST00000225873.9 | NP_000277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX12 | ENST00000225873.9 | c.744_745insT | p.Thr249TyrfsTer14 | frameshift_variant | 3/3 | 1 | NM_000286.3 | ENSP00000225873 | P1 | |
PEX12 | ENST00000586663.2 | c.744_745insT | p.Thr249TyrfsTer14 | frameshift_variant | 3/3 | 1 | ENSP00000466894 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 250122Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135316
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 3A (Zellweger) Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 1997 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 25, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change creates a premature translational stop signal (p.Thr249Tyrfs*14) in the PEX12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 111 amino acid(s) of the PEX12 protein. This variant is present in population databases (rs61752108, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome (PMID: 9090384, 9792857). This variant is also known as c.744_745insT. ClinVar contains an entry for this variant (Variation ID: 553741). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects PEX12 function (PMID: 9090384). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the PEX12 protein in which other variant(s) (p.Leu297Thrfs*12) have been determined to be pathogenic (PMID: 9792857, 14571262, 21031596, 25287621, 26094004). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Peroxisome biogenesis disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 06, 2022 | Variant summary: PEX12 c.744dupT (p.Thr249TyrfsX14) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 8e-06 in 250122 control chromosomes (gnomAD). c.744dupT has been reported in the literature in individuals affected with Zellweger Syndrome (e.g. Chang_1997, Ebberink_2011). One of these patients was shown to have impaired PTS1- and PTS2-protein transport, and reduced PEX12 mRNA levels (Chang_1998). These data indicate that the variant is likely to be associated with disease. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2019 | Observed with a variant on the opposite allele (in trans) in a patient with Zellweger syndrome in the published literature (Chang et al., 1997; Chang and Gould, 1998; Ebberink et al., 2011); Frameshift variant predicted to result in protein truncation, as the last 111 amino acids are replaced with 13 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 9090384, 9792857, 21031596) - |
Peroxisome biogenesis disorder type 3B;C3553929:Peroxisome biogenesis disorder 3A (Zellweger) Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Sep 08, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at